Immune checkpoint inhibitors – why they matter in today's cancer research
Cancer research hinges on developing improved methods to effectively lyse cancer cells. This is where immune checkpoint inhibitors come into direct focus
22nd August 2018
Cancer research hinges on developing improved methods to effectively lyse cancer cells. This is where immune checkpoint inhibitors come into direct focus
22nd August 2018
Why patient centricity throughout the lifecycle is not a fad, sales tactic or trend
17th July 2018
Simon Grime, director of Fendix, explains how pharma can utilise its wealth of existing resources and content to improve collaboration with the NHS online
16th July 2018
Peter Cherry, PhD, Medmeme’s vice president, information systems, explores how pharma can identify predatory journals and conferences
12th July 2018
The importance of a patient-centric focus to improve the real-world use of medicine was extensively discussed during the 3rd Annual Patient Engagement and Experience Conference (16–17th May 2018, Amsterdam, Netherlands).
27th June 2018
The ongoing migration of healthcare currency, from volume to value, is reshaping the healthcare ecosystem. A recent spate of vertical integration, the arrival of new players and partnerships, and the reinvention of the PBMs, continue to disrupt and transform the healthcare value chain
15th May 2018
Medical conferences provide one of the most valuable opportunities for pharma to engage with key stakeholders, but until recently, it was extremely difficult to gather and analyse relevant information from conference data
15th May 2018
It seems as if the conversation around the nature of healthcare’s AI future is one that’s been conducted without the voices of patients themselves
23rd April 2018
Patient support programmes (PSPs) provide one of the biggest opportunities for pharma to put a patient-centric philosophy into practice
23rd April 2018